Evaluating the MobileLink Hip Prosthesis System Outcomes
Official title: Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
Run by Waldemar Link GmbH & Co. KG · NCT04688593 · Data updated 2026-11-12
This study is looking at how well the MobileLink hip replacement system works and how satisfied patients are after getting it.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 520 (estimated) |
| Sponsor | Waldemar Link GmbH & Co. KG Industry-sponsored |
| Locations | 2 sites (Kiel and 1 other locations) |
| Status | Recruiting |
| Started | May 4, 2021 |
| Main results expected | January 2036 |
| Study ends | January 2036 |
| Registry record updated | January 25, 2024 |
| Trial ID | NCT04688593 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are undergoing implantation of the MobileLink acetabular cup system.
✕Probably not a fit
Patients requiring revision surgeries, those with a BMI of 40 kg/m² or higher, or individuals who cannot comply with study requirements will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect clinical data on the MobileLink acetabular cup system used in hip replacement surgeries. It focuses on assessing the short-, mid-, and long-term outcomes of the prosthesis under routine conditions, including patient satisfaction. The study involves patients who have undergone implantation of the MobileLink system and will monitor their progress over time. The data collected will help understand the effectiveness and reliability of this hip prosthesis.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term performance and patient satisfaction associated with the MobileLink hip prosthesis.
How similar studies have gone: Other studies on hip prosthesis systems have shown positive outcomes, indicating that this approach is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link * Age ≥ 18 years * Fully signed patient informed cons Exclusion Criteria: * Revisions * Body Mass Index (BMI) ≥ 40 kg/m² * Patient who is foreseeable not able to understand the study and the study-related circumstances * Patients who is foreseeable non-compliant to the treatment and the follow-ups * Pregnant or breast-feeding women * Prisoner
Where it's running
-
Lubinus Stiftung
Kiel, Germany Recruiting -
NHS FIFE Victoria Hospital
Kirkcaldy, United Kingdom Recruiting
Study contacts
- Study coordinator: Lisa Skottke, PhD
- Email: l.skottke@link-ortho.com
- Phone: +494053995673
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intravenous dexamethasone for better pain control after hip replacement with a PENG block
This study tests whether giving dexamethasone through a vein, in 0, 4, or 8 mg doses, helps control pain after total hip arthroplasty when used with a PENG block.
-
Collecting patient-reported outcomes after hip and knee surgeries
This study is collecting feedback from people who have had hip or knee surgeries to see how well they are doing and how satisfied they are after their operations.
-
Ceramic hip resurfacing vs total hip arthroplasty for hip OA
This trial tests whether ceramic hip resurfacing helps people with hip OA walk farther each day than a modern total hip replacement.
-
Collarless Actis hip stem for cementless hip replacement in Asian patients
This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.
-
Dexmedetomidine during hip replacement to modulate nerves and inflammation
A randomized, placebo-controlled study tests whether intravenous dexmedetomidine given during spinal anesthesia with a PENG nerve block can help regulate the body's stress and inflammatory response and improve recovery after hip replacement.
-
Tipmed Revision Hip Prosthesis: 24-Month Post-Market Follow-Up
This PMCF study tests the safety and how well the Tipmed Revision Hip Prosthesis works in adults undergoing hip revision surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.